Guideline-Concordant Multimodality Care Tied to Fewer Deaths in High-Risk Prostate Cancer Guideline-Concordant Multimodality Care Tied to Fewer Deaths in High-Risk Prostate Cancer

In high-risk prostate cancer patients with at least one additional adverse feature, guideline-concordant multimodal care was associated with greater prostate cancer-specific survival in a large retrospective study.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news